WHO ICTRP trial
Evaluation of the impact of eicosapentaenoic acid on postprandial hyperglycemia…
JPRN-UMIN000011265 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000011265 |
|---|---|
| Public title | Evaluation of the impact of eicosapentaenoic acid on postprandial hyperglycemia, hyperliopemia and endothelial dysfunction in mild diabetic and impaired glucose tolerance patients with coronary artery disease. |
| Scientific title | Evaluation of the impact of eicosapentaenoic acid on postprandial hyperglycemia, hyperliopemia and endothelial dysfunction in mild diabetic and impaired glucose tolerance patients with coronary artery disease. - Evaluation of the impact of eicosapentaenoic acid on postprandial hyperglycemia… |
| Primary sponsor | Hyogo Brain and Heart Center |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | untreated mild diabetic patients (HbA1c<7.0%) and impaired glucose tolearence |
| Interventions | eicosapentanoeic acid life style improvement |
| Registration date | Aug 13, 2013 |
| Target size | 80 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: